ArticlePDF Available

A case report of Gilbert Syndrome

Authors:
  • Mother and Infant Research Activities

Abstract

Gilbert syndrome is benign, often familial condition characterized by recurrent but asymptomatic mild unconjugated hyperbilirubinemia in the absence of haemolysis or underlying liver disease. If, it becomes apparent, it is not until adolescence and then usually in association with stress such as intercurrent illness, fasting or strenuous exercise. Virtually all patients have decreased level of UDP-Glucuronosyltransferase, but there also is evidence for a defect in hepatic uptake of bilirubin as well. This case is reported due to its rarity. The prevalence of Gilbert syndrome in U.S is 3-7% of the population.
187
Case Note
A case report of Gilbert Syndrome
Manandhar SR¹, Gurubacharya RL², Baral MR³, Manandhar DS
4
1
Medical officer,
2
Lecturer,
3
Professor,
4
Professor and HOD, Department of Paediatrics Kathmandu Medical College
Teaching Hospital
Abstract
Gilbert syndrome is benign, often familial condition characterized by recurrent but asymptomatic mild unconjugated
hyperbilirubinemia in the absence of haemolysis or underlying liver disease. If, it becomes apparent, it is not until
adolescence and then usually in association with stress such as intercurrent illness, fasting or strenuous exercise.
Virtually all patients have decreased level of UDP- Glucuronosyltransferase, but there also is evidence for a defect
in hepatic uptake of bilirubin as well. This case is reported due to its rarity. The prevalence of Gilbert syndrome in
U.S is 3-7% of the population.
Keywords: Gilbert Syndrome, familial non-haemolytic jaundice, hereditary non-haemolytic bilirubinaemia, low-
grade chronic hyperbilirubinemia
ugustine Gilbert and Pierre Lereboullet first
described Gilbert syndrome, the most common
inherited cause of unconjugated hyperbilirubinemia,
in 1901. Both autosomal recessive and autosomal
dominant patterns have been described. The
syndrome is characterized by intermittent jaundice in
the absence of haemolysis or underlying liver
disease. The hyperbilirubinemia is mild and by
definition < 6 mg/dl. However, most patients exhibit
levels of 3 mg/dl. Considerable daily and seasonal
variations are observed and bilirubin level
occasionally may be normal in as many as one -third
of patients.
Gilbert syndrome may be precipitated by
dehydration, fasting menstrual periods or stress, such
as an intercurrent illness or vigorous exercise.
Patients may complain of vague abdominal
discomfort and general fatigue for which no cause is
found. These episodes resolve spontaneously and no
treatment is required except for supportive care.
Case report
A 14 year old boy hailing from Bishal Nagar,
Kathmandu admitted in Paediatric ward KMCTH
with history of yellowish discolouration of sclera for
10 days. There were no other complaints. Urine
colour was normal. Child had history of similar
illness one year back and also 3 months back, which
subsided on its own. For present complaint, child was
shown to Ayurvedic doctor who advised restriction of
diet including fatty meals. However, mother noticed
the deepening of jaundice in sclera without any
abnormality in urine colour. On physical
examination, mild jaundice present, but no other
abnormal physical findings were evident.
Investigations done revealed normal haemoglobin,
total and differential count ESR and adequate
platelets. Reticulocyte was within normal limit
(0.5%). Peripheral blood picture showed no
abnormality including any features of haemolysis.
Osmotic fragility done was within normal limit. Liver
function tests were all within normal limit including
HBsAg and AntiHCV with the exception of
unconjugated hyperbilirubinemia on several
occasions.
The maximum total and indirect serum bilirubin
reached were 5.3mg/dl and 4.9mg/dl respectively.
Thus, keeping possibility of Gilbert syndrome, child
was subjected to further test, that is, fasting or
provocation test (child kept on 400Kcal/day for 48
hours). Results found as follows;
Before fasting:
Serum bilirubin Total-1.5 mg/dl
Indirect-0.75 mg/dl
After 48 hours of fasting:
Serum bilirubin: Total-3.61mg/dl
Indirect-2.16 mg/dl
Urine, stool and chest radiograph examinations done
all were within normal limits.
Correspondence:
Dr. Rajesh Lal Gurubacharya, Lecturer, Dept of Paediatrics,
KMCTH, Sinamangal, KTM.
E-mail: rajesh_pul@rediff.com/hotmail.com
A
Kathmandu University Medical Journal (2003) Vol. 1, No. 3, 187-189
188
USG Abdomen was also normal.
Discussion
Unconjugated hyperbilirubinemia in Gilbert
syndrome has long been recognized as due to under
activity of the conjugating enzyme system Uridine
diphosphate glucuronosyltransferase (UDPGT).
Bilirubin UDPGT is responsible for conjugating
bilirubin into bilirubin monoglucuronides and
diglucuronides and is located primarily in the
endoplasmic reticulum of hepatocytes. The UGT1
gene locus for Gilbert syndrome is located on
chromosome 2 and is responsible for virtually all
bilirubin conjugation and UGT2 playing little, if any
role.
Gilbert syndrome is a benign condition with no
associated morbidity or mortality affecting all races
occurring predominantly in men with a male to
female ratio ranging from 2:1-7:1. It usually is
diagnosed around puberty, possibly due to inhibition
of bilirubin glucuronidation by endogenous steroid
hormones. In older subjects, the diagnosis is usually
made when unconjugated hyperbilirubinemia is noted
on routine blood tests or unmasked by an intercurrent
illness or stress.
Diagnosis of Gilbert syndrome can be made in the
presence of (1) unconjugated hyperbilirubinemia
noted on several occasions;(2) normal results on
CBC, reticulocyte count, and blood smear;(3) normal
liver function test results; and absence of other
disease processes. Additional tests are rarely required
for a diagnosis as it is straightforward. However,
following investigations are performed occasionally
to confirm a diagnosis of Gilbert syndrome.
Fasting: This usually results in a 2- to 3- fold
rise in plasma unconjugated bilirubin within
48 hours of a fast that returns to normal levels
within 24 hours of resuming a normal diet.
Although unconjugated bilirubin levels also
rise with fasting in patients with haemolysis or
liver disease, the magnitude of the rise is less
than that observed with Gilbert syndrome. A
similar rise in plasma bilirubin also is
observed with normocaloric diets deficient in
lipids and reverse promptly with lipid
replacement.
Nicotinic acid: Intravenous administration of
50 mg of nicotinic acid results in a 2-to3- fold
rise in plasma unconjugated
hyperbilirubinemia within 3 hours.
Phenobarbital: Phenobarbital and other
enzyme inducers of the bilirubin-UDPGT
system will normalize plasma bilirubin in
patients with Gilbert syndrome.
Rifampicin test: This test is popular because
of non-invasive in nature. It is as reliable as
fasting test. Per oral administration of 600-900
mg of rifampicin results in rise in plasma
unconjugated hyperbilirubinemia within 2-4
hours.
Thin-layer chromatography: This test is
diagnostic for Gilbert syndrome when it shows
a significantly higher proportion of
unconjugated bilirubin when compared to
individuals with chronic haemolysis, liver
disease or those who are healthy. If
confirmation of the diagnosis is truly essential,
chromatographic determination is of potential
use. This will show an increased ratio of
bilirubin monoglucuronide to diglucuronide,
reflecting reduced bilirubin-UDPGT activity.
Polymerase chain reaction: The polymerase
chain reaction (PCR) is a novel and rapid
method of identifying genetic polymorphisms
in the TATA box of the UDPGT1 gene using
fluorescence resonance energy transfer.
Liver biopsy: It is not performed routinely and
is rarely necessary for a diagnosis. Liver is
normal histologically.
Conclusion
In the light of above case, if a child comes with
isolated unconjugated hyperbilirubinemia (< 6 mg/dl)
on several occasions in the absence of haemolysis or
underlying liver disease; Gilbert syndrome should be
entertained in the differential diagnosis of
unconjugated hyperbilirubinemia, being the most
common inherited cause. It has no deleterious
associations and an excellent prognosis, and those
who have it can lead a normal lifestyle.
Acknowledgement
Sincere thanks to Dr. I.L. Shrestha for kindly
performing fasting test and also to Department of
pathology KMCTH.
References
1. Aono S, Adachi Y, Uyama E: Analysis of
genes for bilirubinUDP-
glucuronosyltransferase in Gilbert syndrome.
Lancet 1995 Apr 15; 345(8955): 958-9
2. Borlak J, Thum T, Landt O: Molecular
diagnosis of a familial nonhemolytic
hyperbilirubinemia (Gilbert syndrome) in
healthy subjects. Hepatology 2000 Oct; 32(4
Pt 1): 792-5
3. Ohkubo H, Okuda K, Iida S: Effects of
corticosteroids on bilirubin metabolism in
189
patients with Gilbert syndrome. Hepatology
1981 Mar-Apr; 1 (2): 168-72
4. Siege A, Stiehl A, Raedsch R: Gilbert
syndrome: Diagnosis by typical serum
bilirubin pattern. Clin Chim Acta 1986 Jan 15;
154(1): 41-7
5. Balistrer W F, Inherited deficient conjugation
of bilirubin. In: Nelson textbook of ped. 16
th
Edn. Behrman R F, Kleigman R H, Jenson B
(eds). Harcourt Asia pte Ltd 2000; pp 1208-9
6. Whitmer D I, Gollan J L: Mechanisms and
significance of fasting dietary
hyperbilirubinemia. Semin Liver Dis 1983
Feb; 3(1): 42-51
7. Erdil A, Ates Y, Bagei S, Uygun A, Dagalp
K.Rifampicin test in the diagnosis of Gilbert
syndrome. Int. J Clin Pract 2001Mar; 55(2):
81-3
8. Murthy G D, Byron D, Shoemaker D,
Visweswaraiah H, Pasquale D. Rifampicin test
in the utility of Gilbert syndrome. Am J
Gatroenterol 2001 Apr; 96(4): 1150-4
9. Sherlock D S. The familial non-hemolytic
hyperbilirubinemia : In Disease of the liver
and biliary system.6
th
Edn;pp203-204
190
Correspondence
Dr. Rajesh Lal Gurubacharya,Lecturer,Dept of Pediatrics,KMCTH
5. Sinamangal,KTM,rajesh_pul@rediff.com/hotmail.com
... In 1901, Gilbert's syndrome (GS) was first described by Augustin Nicolas Gilbert and Pierre Lereboullet as benign, familial, fluctuating, mild, and unconjugated hyperbilirubinemia without underlying hemolysis and with normal routine tests of liver function and liver histopathology and named it as "La cholemie simple familiale." 1,2 Subsequently, it was further elaborated by Meulengracht in 1946 and Arias et al. in 1962. Gilbert's syndrome is the most common inherited cause of unconjugated hyperbilirubinemia, others being Crijlar-Najar syndrome I (CN I) and Crijlar-Najar syndrome II (CN II). ...
... Patients usually complain of vague abdominal discomfort, malaise, and generalized weakness, which are resolved spontaneously with reassurance and supportive care without any treatment. 2 Since the time it was first described, GS was considered a benign clinical entity without any morbidity and mortality and excellent prognosis. However recently, many studies have proposed that affected individuals may be more prone to develop liver injury following treatment with various drugs, such as paracetamol, propofol, irinotecan, indinavir, and xenobiotics. ...
... Patients usually reports with vague symptoms of malaise, nausea, recurrent vomiting, and abdominal discomfort over liver without any evidence of hepatomegaly or any other systemic abnormality. 2 On exanimation, jaundice is mild, intermittent with serum bilirubin levels <6 mg/dL. However, in one-third of cases, serum bilirubin level may be normal to <3 mg/dL. ...
Article
Full-text available
t Gilbert’ syndrome (GS), most common hereditary cause of unconjugated hyperbilirubinemia due to polymorphisms in uridine diphosphate glucuronosyltransferase (UGT) enzyme, was first described by Augustin Nicolas Gilbert and Pierre Lereboullet in 1901. It becomes apparent around adolescence and often precipitated by prolonged fasting, intercurrent illness, or strenuous exercise. Gilbert’s syndrome has an excellent prognosis and does not require any treatment. But recent studies have shown that patients with GS are more susceptible to enhanced toxicity of several drugs using UGT enzyme in their metabolism. Also, hyperbilirubinemia is protective due to its anti-inflammatory, anti-oxidant, and anti-cancer properties, particularly in colon cancer. In India, followers of different religious practice a ritualistic prolonged fastings, which can predispose susceptible cases of GS to unconjugated hyperbilirubinemia. We report a rare case of GS unmasked by ritualistic prolonged fasting of Chhath Puja in Bihar to increase awareness about it among medical fraternity and patients.
... In 1901, Gilbert's syndrome (GS) was first described by Augustin Nicolas Gilbert and Pierre Lereboullet as benign, familial, fluctuating, mild, and unconjugated hyperbilirubinemia without underlying hemolysis and with normal routine tests of liver function and liver histopathology and named it as "La cholemie simple familiale." 1,2 Subsequently, it was further elaborated by Meulengracht in 1946 and Arias et al. in 1962. Gilbert's syndrome is the most common inherited cause of unconjugated hyperbilirubinemia, others being Crijlar-Najar syndrome I (CN I) and Crijlar-Najar syndrome II (CN II). ...
... Patients usually complain of vague abdominal discomfort, malaise, and generalized weakness, which are resolved spontaneously with reassurance and supportive care without any treatment. 2 Since the time it was first described, GS was considered a benign clinical entity without any morbidity and mortality and excellent prognosis. However recently, many studies have proposed that affected individuals may be more prone to develop liver injury following treatment with various drugs, such as paracetamol, propofol, irinotecan, indinavir, and xenobiotics. ...
... Patients usually reports with vague symptoms of malaise, nausea, recurrent vomiting, and abdominal discomfort over liver without any evidence of hepatomegaly or any other systemic abnormality. 2 On exanimation, jaundice is mild, intermittent with serum bilirubin levels <6 mg/dL. However, in one-third of cases, serum bilirubin level may be normal to <3 mg/dL. ...
Article
Full-text available
Gilbert' syndrome (GS), most common hereditary cause of unconjugated hyperbilirubinemia due to polymorphisms in uridine diphosphate glucuronosyltransferase (UGT) enzyme, was first described by Augustin Nicolas Gilbert and Pierre Lereboullet in 1901. It becomes apparent around adolescence and often precipitated by prolonged fasting, intercurrent illness, or strenuous exercise. Gilbert's syndrome has an excellent prognosis and does not require any treatment. But recent studies have shown that patients with GS are more susceptible to enhanced toxicity of several drugs using UGT enzyme in their metabolism. Also, hyperbilirubinemia is protective due to its anti-inflammatory, anti-oxidant, and anti-cancer properties, particularly in colon cancer. In India, followers of different religious practice a ritualistic prolonged fastings, which can predispose susceptible cases of GS to unconjugated hyperbilirubinemia. We report a rare case of GS unmasked by ritualistic prolonged fasting of Chhath Puja in Bihar to increase awareness about it among medical fraternity and patients.
... [3,[5][6][7] Thus, the serum bilirubin in GS is usually <4 mg/dl. [2,5,6,14,15] This is consistent with the reported case (his serum bilirubin level is usually around 2.4 mg/dl. On the other hand, Flores-Villalba et al. reported cases of GS that presented atypically with severe jaundice with unconjugated bilirubin levels of more than 10 mg/dl. ...
Article
Full-text available
Jaundice is a well-known condition that is commonly encountered during daily clinical practice. However, recurrent episodes of jaundice in which the unconjugated bilirubin is predominant without evidence of hemolysis have very restricted differential diagnoses, the most common of which is Gilbert’s syndrome (GS). Here, we reported a case of GS in a young adult in whom the recurrent attacks of jaundice were triggered by stressful situations. GS is a benign inherited condition that does not lead to liver cell injury; hence reassurance and avoidance of the triggering factors including a wide list of medications represent the cornerstones for the management of this condition.
... Apart from clinical factors, genetic factors have also been associated with neonatal jaundice [4]. Considerable daily and seasonal variations in serum bilirubin levels have been observed in patients with Gilbert's syndrome (GS), a benign deficiency in bilirubin glucuronidation [36]. GS is associated with a homozygous polymorphism, A(TA)7TAA, in the TATA-box of the promoter region of the bilirubin UGT1A1 gene [37]. ...
Article
Full-text available
To establish whether serum bilirubin levels vary in healthy term neonates according to seasonal variations and meteorological factors, we retrospectively studied 3344 healthy term neonates born between 2013 and 2018. Total serum bilirubin (TSB) levels were measured on the fourth day after birth. The monthly and seasonal variations in TSB levels and clinical and meteorological effects on TSB levels were assessed. In the enrolled neonates, the median TSB level was 195 µmol/L. The TSB level peaked in December and was the lowest in July, but the variation was not statistically significant. The TSB level was significantly higher in the cold (October to March) than in the warm season (April to September; p = 0.01). The comparison between seasonal differences according to sex showed TSB levels were significantly higher in the cold than in the warm season in male infants (p = 0.001), whereas no significant difference was observed in female infants. A weakly negative but significant association existed between TSB levels and the mean daily air temperature (r = −0.07, p = 0.007) in only the male population; the female population showed no significant correlation between TSB levels and meteorological parameters. The season of birth is an etiological factor in neonatal jaundice, with an additional influence from sex.
... Gilbert syndrome. A case of Gilbert syndrome in a 14 year old boy diagnosed on the basis of normal blood counts and liver function tests, as well as a rise in unconjugated bilirubin on 48 h fasting, has been reported [38]. ...
Article
Full-text available
Background: The prevalence of metabolic disease in Nepal is largely unknown. Some consideration has been given by the nepalese government for high prevalence of congenital disorders in some populations, but disorders due to enzymatic deficiencies have not been considered as a class of diseases where timely diagnosis and intervention might be possible. No case for these disorders has been made so far, however, findings of many rare metabolic diseases have been reported in literature by the nepalese medical fraternity. Methods: A search for case reports on metabolic disorders listed according to International Classification of Diseases -11 was performed using the google search engine. Results: A total of 443 cases have been discovered presented in the literature. This does not include disorders that might be due to lifestyle and behaviour. Most of the reported cases have been identified based on clinical acumen, radiological and histopathological findings. Conclusions: Glucose 6 phosphate dehydrogenase deficiency, Wilson's disease and lysosomal disorders should be considered for early diagnosis through newborn screening along with the acknowledged disorders hypothyroidism and hemoglobinopathies in Nepal. Early intervention in these disorders can significantly reduce morbidity and mortality in infancy.
... G ilbert Syndrome (GS) is a common autosomal dominant hereditary condition characterized by recurrent mild unconjugated hyperbilirubinaemia in the absence of haemolysis or underlying liver diseases. 1,2 Augustin Gilbert and Pierre Lereboullet first reported this disease in 1901. GS is rarely diagnosed before puberty though it is a congenital disease. ...
Article
Full-text available
Gilbert syndrome (GS) is mainly characterized by intermittent unconjugated hyperbilirubinemia in the absence of hepatocellular disease or hemolysis. Little data are available on operative outcomes in GS patients with spinal deformity surgery. This study has presented a case of GS occurring in the patient with scoliosis. The patient was a 30-year-old female with scoliosis and GS. She was taken a correction form Thoracic 2 to Lumbar 1) levels by using the USS-II spinal system. At 2 years follow-up, the patient was well balanced and pain free. Plain radiographs demonstrated spine solid fusion without correction loss. Although complex scoliosis surgery can be performed safely in these patients with GS, careful perioperative managements including liver function and coagulation function are required.
Article
Full-text available
Gilbert syndrome characterized by jaundice with intermittent elevations of indirect bilirubin, in the absence of haemolysis or underlying liver disease, has both autosomal dominant and recessive inheritance. Crigler-Najjar syndrome type II (CNS2) is a hereditary disorder of bilirubin metabolism characterized by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). We report 20 children between age 5 to 15 years with unconjugated hyperbilirubenemia who were given seven days of oral phenobarbitone (5mg/kg/day) and decrease in level of bilirubin was noted. There was only 30-40% reduction of bilirubin in Crigler Najjar Syndrome Type 2 compared to Gilberts Syndrome in which bilirubin level normalised. This case series highlights the importance of simple test to differentiate these two condition. This test is also very helpful in a place where enzyme level and mutational study cannot be done.
Article
Analysis of serum unconjugated and conjugated bilirubin fractions by routine diazo procedures does not allow a definite diagnosis of Gilbert's syndrome. By the alkaline methanolysis procedure of Blanckaert followed by thin-layer chromatography we were able to discriminate Gilbert's syndrome even in the presence of normal serum bilirubin concentrations from healthy subjects, patients with chronic persistant hepatitis and patients with chronic hemolysis. The relative proportion of unconjugated bilirubin in serum was 95 +/- 2% in patients with Gilbert's syndrome (n = 28), 84 +/- 5% in healthy subjects (n = 29), 75 +/- 6% in patients with chronic persistant hepatitis (n = 7) and 85 +/- 3% in patients with chronic hemolysis (n = 9). The difference between Gilbert's syndrome and the control groups with normal or elevated serum bilirubin was highly significant (p less than 0.001). In Gilbert's syndrome, unconjugated bilirubin ranged between 90 and 99%, in healthy subjects between 72 and 90%, in patients with chronic persistant hepatitis between 68 and 85% and in patients with chronic hemolysis between 81 and 89% of total. An overlap was only seen in one patient with Gilbert's syndrome and in 2 healthy subjects at the 90% level. We conclude that in most patients with Gilbert's syndrome provocation tests are no longer necessary.
Article
To elucidate the mechanism whereby corticosteroids decrease the serum bilirubin concentration, changes in bilirubin metabolism were studied in patients with Gilbert's syndrome using a bilirubin load test and/or nicotinic acid test before and after corticosteroid treatment. Steroid administration increased hepatic clearance and uptake of bilirubin; the transfer rate for biliary excretion was unaffected. These results suggest that the main effect was enhancement of hepatic uptake or storage of bilirubin, which may be an important mechanism whereby corticosteroids reduce serum bilirubin concentrations in various liver disorders.
Article
Gilbert's and Crigler-Najjar syndromes are characterised by unconjugated hyperbilirubinaemia due to complete and partial absence of bilirubin UDP-glucuronosyltransferase (UGT). Nucleotide sequences of the genes for bilirubin UGT were analysed in six patients with Gilbert's syndrome. All patients had a missense mutation caused by a single nucleotide substitution and the mutations were heterozygous. In addition, relatives of patients with Crigler-Najjar syndrome types I and II, and of those with Gilbert's syndrome were analysed. All ten relatives with mild hyperbilirubinaemia were heterozygotes with respect to each defective allele. These results suggest that Gilbert's syndrome is inherited as a dominant trait.
Article
To show the effectiveness and feasibility of the Rifampicin test in diagnosing Gilbert's syndrome. A prospective, descriptive study. SITE. General Medical Service of the Navarra Hospital. 17 patients with bilirubin levels on two or more occasions and 6 healthy patients without these data. Both in- and out-patients. The Rifampicin test. Bilirubin levels were determined when fasting and one, two, three and four hours after taking 900 mg of Rifampicin (Rimactan). After the test, those patients who had Gilbert's disease presented bilirubin levels significantly higher than the healthy patients, who remained within normal levels. In the group studied, the Rifampicin test demonstrated its effectiveness in the diagnosis of suspected Gilbert's disease. It would therefore be possible to use this test in the Primary Care field.
Article
Recent research has shown that congenital nonhemolytic low grade hyperbilirubinemias in patients with Gilbert's syndrome (GS) are linked to mutations in the TATA box upstream of the uridine 5'-diphosphoglucose glucuronosyltransferase (UGT1A1) gene leading to an impaired bilirubin glucuronidation. In routine clinical practice GS patients can, however, only be suspected by exclusion of other causes of hyperbilirubinemia or substantial liver diseases. We developed a new, sensitive, convenient, and economic polymerase chain reaction (PCR) method for the rapid and reliable identification of gene polymorphisms in the TATA box of the UGT1A1 gene using fluorescence resonance energy transfer (FRET). With this procedure the genotype frequency in a cohort of 266 unrelated individuals from Southern Germany was investigated and the allelic distribution for individual genotypes was 43:45:12 for the (TA)(6)TAA:(TA)(6)TAA/(TA)(7)TAA:(TA)(7)TAA alleles, respectively. The homozygous (TA)(7)TAA genotype was strongly associated with suspected Gilbert's patients and its prevalence in our cohort of 266 Southern German individuals was 12.4%. In this cohort total mean serum bilirubin levels ranged from 5 micromol/L (wild-type 6/6 allele) to 57 micromol/L serum total bilirubin (mutant 7/7 homozygous allele). Median (interquartile range) serum total bilirubin levels were 12 (6) and 21 (13) for the homozygous wild-type and mutant allele, respectively. Our assay enables individual guidance for dose adjustment in suspected GS patients undergoing long-term drug therapies, especially if glucuronidation via UGT1A1 is a major metabolic pathway.
Article
Gilbert's syndrome (GS) is characterised by the existence of chronic mild unconjugated hyperbilirubinaemia. The value of rifampicin as a provocative test for the diagnosis of GS was evaluated and compared with a fasting test. Twenty-two patients with GS, 15 patients with chronic liver disease and 20 healthy controls were included. Both rifampicin and fasting tests were applied to all subjects. In the fasting test, the subjects were given a 400 calorie/day diet for 24 hours; in the rifampicin test, unconjugated bilirubin levels was measured before and four hours after taking 600 mg of rifampicin. Both tests achieved a significant increase in mean unconjugated bilirubin levels in patients with GS but not in the controls. The sensitivity and specificity of a rifampicin test in the diagnosis of GS were comparable with the fasting test. However, both tests caused a significant increase in unconjugated bilirubin levels in nearly half the patients with chronic liver disease. A rifampicin test may be used in the diagnosis of suspected GS instead of a fasting test, as it is simpler and more practical. However, its specificity for GS is not sufficient, because it also causes an increase in unconjugated bilirubin levels in some patients with chronic liver disease.
Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert syndrome) in healthy subjects 3. Ohkubo H, Okuda K, Iida S: Effects of corticosteroids on bilirubin metabolism in 189 patients with Gilbert syndrome
  • J Borlak
  • T Thum
  • Landt
Borlak J, Thum T, Landt O: Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert syndrome) in healthy subjects. Hepatology 2000 Oct; 32(4 Pt 1): 792-5 3. Ohkubo H, Okuda K, Iida S: Effects of corticosteroids on bilirubin metabolism in 189 patients with Gilbert syndrome. Hepatology 1981 Mar-Apr; 1 (2): 168-72
Inherited deficient conjugation of bilirubin In: Nelson textbook of ped
  • W Balistrer
  • Edn
  • R F Behrman
  • R H Kleigman
  • Jenson
Balistrer W F, Inherited deficient conjugation of bilirubin. In: Nelson textbook of ped. 16 th Edn. Behrman R F, Kleigman R H, Jenson B (eds). Harcourt Asia pte Ltd 2000; pp 1208-9
The familial non-hemolytic hyperbilirubinemia : In Disease of the liver and biliary system.6 th Edn
  • D Sherlock
Sherlock D S. The familial non-hemolytic hyperbilirubinemia : In Disease of the liver and biliary system.6 th Edn;pp203-204